Title : Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer.

Pub. Date : 2022

PMID : 35165514






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Mechanistically, gemcitabine and XCT790 suppressed PC by inhibiting ERRalpha and MEK/ERK signaling pathway. gemcitabine mitogen-activated protein kinase 1 Homo sapiens